Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels

被引:4
|
作者
Saad, Fred [1 ]
机构
[1] Univ Montreal, Ctr Hosp, Montreal, PQ H2L 4M1, Canada
关键词
D O I
10.1016/j.eururo.2014.08.033
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:837 / 838
页数:2
相关论文
共 50 条
  • [1] PROSTATE-SPECIFIC ANTIGEN AND ANDROGEN DEPRIVATION THERAPY
    RUCKLE, HC
    OESTERLING, JE
    [J]. WORLD JOURNAL OF UROLOGY, 1993, 11 (04) : 227 - 232
  • [2] Prostate-Specific Antigen Kinetics under Androgen Deprivation Therapy and Prostate Cancer Prognosis
    Zhang, Li-min
    Jiang, Hao-wen
    Tong, Shi-jun
    Zhu, Hui-qing
    Liu, Jun
    Ding, Qiang
    [J]. UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 38 - 48
  • [3] Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression
    Akbay, Erdem
    Bozlu, Murat
    Cayan, Selahittin
    Kara, Pelin Ozcan
    Tek, Mesut
    Aytekin, Cuma
    [J]. AGING MALE, 2017, 20 (03): : 175 - 183
  • [4] FIBROBLASTS PROLONG SERUM PROSTATE-SPECIFIC ANTIGEN DECLINE AFTER ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
    Sasaki, Takeshi
    Ishii, Kenichiro
    Miki, Manabu
    Kanda, Hideki
    Arima, Kiminobu
    Shiraishi, Taizo
    Sugimura, Yoshiki
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E818 - E818
  • [5] Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer
    Sasaki, Takeshi
    Ishii, Kenichiro
    Iwamoto, Yoichi
    Kato, Manabu
    Miki, Manabu
    Kanda, Hideki
    Arima, Kiminobu
    Shiraishi, Taizo
    Sugimura, Yoshiki
    [J]. LABORATORY INVESTIGATION, 2016, 96 (03) : 338 - 349
  • [6] Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Liu, Chia-Chu
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Wu, Tony T.
    Huang, Chun-Nung
    Huang, Chun-Hsiung
    Wu, Wen-Jeng
    [J]. AGING MALE, 2012, 15 (01): : 34 - 41
  • [7] Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
    Haines, Ian E.
    Miklos, George L. Gabor
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (20) : 1534 - 1539
  • [8] How early is early: Androgen deprivation for prostate-specific antigen relapse in prostate cancer
    Duchesne, Gillian M.
    Syme, Rodney
    Howell, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2964 - 2964
  • [9] Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer
    Tremblay, Samuel
    Summers-Trasiewicz, Lily
    Pouliot, Frederic
    Crook, Juanita M.
    Ding, Keyue
    Klotz, Laurence
    Toren, Paul
    [J]. JOURNAL OF UROLOGY, 2021, 206 (05): : 1166 - 1175
  • [10] A prospective study of the effect of testosterone escape on preradiotherapy prostate-specific antigen kinetics in prostate cancer patients undergoing neoadjuvant androgen deprivation therapy
    Christie, David R. H.
    Mitina, Natalia
    Sharpley, Christopher F.
    [J]. CURRENT UROLOGY, 2021, 15 (01) : 63 - 67